Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock enjoyed a major increase of 24.2% on 11/27/24. The shares closed at $26.15. Moreover, exceptionally high trading volume at 515% of normal accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 40.6% during the last week.
Current PriceTarget Research Rating
Arrowhead Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Arrowhead Pharmaceuticals has a very low Appreciation Score of 7 and a very low Power Rating of 5, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment